Your browser doesn't support javascript.
loading
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib.
McWilliams, Emily M; Lucas, Christopher R; Chen, Timothy; Harrington, Bonnie K; Wasmuth, Ronni; Campbell, Amanda; Rogers, Kerry A; Cheney, Carolyn M; Mo, Xiaokui; Andritsos, Leslie A; Awan, Farrukh T; Woyach, Jennifer; Carson, William E; Butchar, Jonathan; Tridandapani, Susheela; Hertlein, Erin; Castro, Carlos E; Muthusamy, Natarajan; Byrd, John C.
Afiliação
  • McWilliams EM; Biomedical Sciences Graduate Program, College of Medicine.
  • Lucas CR; Division of Hematology, Department of Internal Medicine, College of Medicine and OSU Comprehensive Cancer Center.
  • Chen T; Department of Mechanical and Aerospace Engineering, College of Engineering.
  • Harrington BK; Biomedical Sciences Graduate Program, College of Medicine.
  • Wasmuth R; Division of Hematology, Department of Internal Medicine, College of Medicine and OSU Comprehensive Cancer Center.
  • Campbell A; Division of Hematology, Department of Internal Medicine, College of Medicine and OSU Comprehensive Cancer Center.
  • Rogers KA; Department of Veterinary Biosciences, College of Veterinary and Comparative Medicine.
  • Cheney CM; Division of Hematology, Department of Internal Medicine, College of Medicine and OSU Comprehensive Cancer Center.
  • Mo X; Biomedical Sciences Graduate Program, College of Medicine.
  • Andritsos LA; Division of Hematology, Department of Internal Medicine, College of Medicine and OSU Comprehensive Cancer Center.
  • Awan FT; Division of Hematology, Department of Internal Medicine, College of Medicine and OSU Comprehensive Cancer Center.
  • Woyach J; Center for Biostatistics.
  • Carson WE; Division of Hematology, Department of Internal Medicine, College of Medicine and OSU Comprehensive Cancer Center.
  • Butchar J; Division of Hematology, Department of Internal Medicine, College of Medicine and OSU Comprehensive Cancer Center.
  • Tridandapani S; Division of Hematology, Department of Internal Medicine, College of Medicine and OSU Comprehensive Cancer Center.
  • Hertlein E; Division of Surgical Oncology, Department of Surgery, College of Medicine and OSU Comprehensive Cancer Center, and.
  • Castro CE; Division of Hematology, Department of Internal Medicine, College of Medicine and OSU Comprehensive Cancer Center.
  • Muthusamy N; Division of Hematology, Department of Internal Medicine, College of Medicine and OSU Comprehensive Cancer Center.
  • Byrd JC; Division of Hematology, Department of Internal Medicine, College of Medicine and OSU Comprehensive Cancer Center.
Blood Adv ; 3(3): 447-460, 2019 02 12.
Article em En | MEDLINE | ID: mdl-30737226
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Leucemia Linfocítica Crônica de Células B / Anticorpos Monoclonais Humanizados Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Leucemia Linfocítica Crônica de Células B / Anticorpos Monoclonais Humanizados Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2019 Tipo de documento: Article